supp.fit

Zinc and Copper: study protocols

57 study groups took Zinc together with Copper. These are the doses the studies gave. They are not a recommendation.

Zinc: what the research found →

Dose per serving from research: Zinc

56 study groups in 36 studies say how much Zinc participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 32% of 56 study groups.

Daily doseStudy groups
5 mg or less
2
5 mg to 10 mg
13
10 mg to 25 mg
18
25 mg to 50 mg
6
50 mg to 100 mg
17

Dose per serving from research: Copper

49 study groups in 34 studies say how much Copper participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 43% of 49 study groups.

Daily doseStudy groups
250 mcg to 500 mcg
8
500 mcg to 1 mg
13
1 mg to 2.5 mg
21
2.5 mg to 5 mg
7

Commonly used together

44 of 57 study groups took Zinc and Copper with something else. Shown: what 3 or more different studies gave. The 10 most common of 23.

What was given together, not what works together.

Taken withStudy groups
Vitamin C
30
Vitamin E
30
Iron
22
Selenium
15
Vitamin A
14
Vitamin D
11
Beta-Carotene
10
Iodine
10
Vitamin B12
10
Folic Acid
9

57 study groups

Study
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
80 mg2 mg8 years—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
80 mg2 mg9 years—
Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis
2016 · zinc · Adults aged 55 years and older with age-related macular degeneration; eyes with advanced disease at baseline and participants with no AMD in both eyes were excluded
80 mg2 mg2409 days—
Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis
2016 · combination of antioxidants and zinc · Adults aged 55 years and older with age-related macular degeneration; eyes with advanced disease at baseline and participants with no AMD in both eyes were excluded
80 mg2 mg2409 days—
Therapeutic evaluation of zinc and copper supplementation in acute diarrhea in children: double blind randomized trial
2005 · zinc and copper supplementation · Children aged 6 months to 59 months with acute diarrhea in an urban hospital
40 mg5 mg—102
Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial
2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India
7.8 mg270 mcg1 year316
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
80 mg2 mg8 years—
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
20 mg2 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
30 mg2 mg——
Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa
2009 · multiple micronutrients · children aged 6–24 months; three cohorts: HIV-infected children, HIV-uninfected children born to HIV-infected mothers, and HIV-uninfected children born to HIV-uninfected mothers
10 mg600 mcg548 days—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
80 mg2 mg9 years—
Effects of therapeutic zinc supplementation for diarrhea and two preventive zinc supplementation regimens on the incidence and duration of diarrhea and acute respiratory tract infections in rural Laotian children: A randomized controlled trial
2020 · MNP group · Children aged 6–23 months in rural Laos
10 mg560 mcg40 weeks852
Effect of preventive supplementation with zinc and other micronutrients on non-malarial morbidity in Tanzanian pre-school children: a randomized trial
2012 · Multi-nutrients with zinc · Children aged 6–60 months with height-for-age z-score ≤−1.5 SD, in rural Tanzania
10 mg340 mcg—151
Zinc and copper supplementation in acute diarrhea in children: a double-blind randomized controlled trial
2009 · zinc and copper (Zn+Cu) arm · Children aged 6–59 months with acute watery or bloody diarrhea
2 mg/kg0.2 mg/kg2 weeks273
Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6-18 months
2014 · zinc, iron, and copper supplement · Infants aged 6–18 months
10 mg500 mcg1 year—
Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women
2011 · 600 mg Ca plus 2 mg Cu and 12 mg Zn · Healthy postmenopausal women aged 51–80 years
12 mg2 mg2 years112
Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals
1994 · trace minerals only · Healthy postmenopausal women, mean age 66 years
15 mg2.5 mg2 years—
Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial
2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering
7.8 mg270 mcg1 year316
Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months
2010 · Multiple micronutrients · Children enrolled at 6 months and followed to 24 months in rural South Africa; HIV-infected and HIV-uninfected children, both sexes
10 mg600 mcg548 days126
Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial
2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly
8 mg—12 weeks40
TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD
2007 · Sham MCS and nutritional supplement · Adults aged 50–90 with dry age-related macular degeneration in at least one eye
69.6 mg1.6 mg24 weeks37
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year
2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years
22.5 mg1 mg1 year15
The effects of antioxidant vitamin supplementation on expiratory flow rates at rest and during exercise
2015 · antioxidant vitamin supplementation (AVS) · healthy nonsmoking adults, 5 men and 5 women, consuming fewer than 5 servings of fruit and vegetables per day
7.5 mg1 mg4 weeks10
[Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial]
2004 · Group 1: Vitrum Osteomag · Postmenopausal women with osteopenia; age range not reported
15 mg2 mg1 year125
Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals
1994 · calcium plus trace minerals · Healthy postmenopausal women, mean age 66 years
15 mg2.5 mg2 years—
The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7
2002 · zinc · Adults aged 55–80 years with early-to-late age-related macular degeneration
80 mg2 mg5 years—
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 2 (Vitalux AREDS) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
25 mg1 mg—10
Zinc supplementation inhibits complement activation in age-related macular degeneration
2014 · Zinc and copper supplement · Adults with age-related macular degeneration; mean age 73.9 years
50 mg1 mg90 days72
The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7
2002 · antioxidants and zinc · Adults aged 55–80 years with early-to-late age-related macular degeneration
80 mg2 mg5 years—
A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women
2004 · Low dietary copper and high-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated
53 mg1 mg90 days—
A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women
2004 · High dietary copper and high-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated
53 mg3 mg90 days—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS zinc only · Adults aged 55–80 with early or more advanced age-related macular degeneration
80 mg2 mg5 years—
Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age
2019 · MMN · Predominantly anemic, nonpregnant women aged 18–45 years
15 mg2 mg12 weeks202
The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers
2018 · LNS · HIV-infected lactating women in Malawi
19 mg300 mcg28 weeks185
Mineral status of non-anemic Peruvian infants taking an iron and copper syrup with or without zinc from 6 to 18 months of age: a randomized controlled trial
2013 · iron + copper + zinc group · Non-anemic Peruvian infants randomized at 6 months of age, born at term and weighing more than 2500 g; followed until 18 months
10 mg500 mcg1 year129
The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers
2018 · ARV + LNS · HIV-infected lactating women in Malawi
19 mg300 mcg28 weeks90
Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects
2003 · 100 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified
12 mg3 mg1 day11
Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects
2003 · 400 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified
12 mg3 mg1 day11
Dose-response trial of prophylactic zinc supplements, with or without copper, in young Ecuadorian children at risk of zinc deficiency
2008 · 10 mg Zn + 0.5 mg Cu as copper sulfate · Ecuadorian children aged 12–30 months at baseline with length-for-age z scores below −1.3, at risk of zinc deficiency
10 mg500 mcg26 weeks—
Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh
2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh
12 mg1 mg165 days749
Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age
2019 · Fe + MMN · Predominantly anemic, nonpregnant women aged 18–45 years
15 mg2 mg12 weeks206
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
12 mg1 mg—176
mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status
2017 · MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia
30 mg4 mg184 days75
mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status
2017 · PE+MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia
30 mg4 mg184 days75
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men
34.8 mg—1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men
69.6 mg—1 day15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men
69.6 mg—1 day15
A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women
2004 · Low dietary copper and low-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated
3 mg1 mg90 days—
A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women
2004 · High dietary copper and low-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated
3 mg3 mg90 days—
Multiple micronutrient supplementation improves micronutrient status in primary school children in Hai Phong City, Vietnam: a randomised controlled trial
2021 · intervention · Children aged 6–9 years, apparently healthy, in rural Hai Phong City, Vietnam; included undernourished, normal-weight, and overweight/obese children
10 mg560 mcg22 weeks175
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
25 mg1 mg—10
Prophylactic iron supplementation in pregnant women in Norway
2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy
10 mg2 mg——
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration
80 mg2 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
80 mg2 mg5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
80 mg—5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
25 mg—5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
25 mg—5 years—